These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22808812)

  • 1. Prevalence of extended spectrum beta lactamase (ESBL) production in gram negative isolates from pyogenic infection in tertiary care hospital of eastern Nepal.
    Shrestha S; Amatya R; Dutta R
    Nepal Med Coll J; 2011 Sep; 13(3):186-9. PubMed ID: 22808812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.
    Ndugulile F; Jureen R; Harthug S; Urassa W; Langeland N
    BMC Infect Dis; 2005 Oct; 5():86. PubMed ID: 16225701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
    Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
    Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA; Angamuthu K
    Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital.
    Mathur P; Kapil A; Das B; Dhawan B
    Indian J Med Res; 2002 Apr; 115():153-7. PubMed ID: 12239838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of extended spectrum beta lactamase in urinary isolates.
    Tankhiwale SS; Jalgaonkar SV; Ahamad S; Hassani U
    Indian J Med Res; 2004 Dec; 120(6):553-6. PubMed ID: 15654142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy.
    Bajpai T; Pandey M; Varma M; Bhatambare GS
    Indian J Pathol Microbiol; 2014; 57(3):407-12. PubMed ID: 25118732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
    Chayakulkeeree M; Junsriwong P; Keerasuntonpong A; Tribuddharat C; Thamlikitkul V
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1503-9. PubMed ID: 16610653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.
    Men TY; Wang JN; Li H; Gu Y; Xing TH; Peng ZH; Zhong L
    Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short communication: prevalence of extended spectrum beta-lactamases in gram negative rods: data of 2001-2004 period].
    Alici O; Açikgöz ZC; Göçer S; Gamberzade S; Karahocagil MK
    Mikrobiyol Bul; 2006 Oct; 40(4):355-61. PubMed ID: 17205693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study.
    Kuo LC; Yu CJ; Kuo ML; Chen WN; Chang CK; Lin HI; Chen CC; Lu MC; Lin CH; Hsieh WF; Chen LW; Chou Y; Huang MS; Lee CH; Chen SC; Thai SL; Chen PC; Chen CH; Tseng CC; Chen YS; Hsiue TR; Hsueh PR
    Int J Antimicrob Agents; 2008 May; 31(5):420-6. PubMed ID: 18358701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
    Biedenbach DJ; Bouchillon SK; Hoban DJ; Hackel M; Phuong DM; Nga TT; Phuong NT; Phuong TT; Badal RE
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):463-7. PubMed ID: 24923210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro Temocillin efficacy against extended spectrum β-lactamase producing multidrug resistant gram negative bacterial isolates from Nepal.
    Kandel BP; Bhatta DR; Shakya G; Upadhayay BP; Dumre SP; Poudyal S; Adhikari N; Acharya D
    Nepal Med Coll J; 2014 Dec; 16(2-4):144-7. PubMed ID: 26930733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
    Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.